Skip to main content
. 2021 Jan 18;3(1):dlaa113. doi: 10.1093/jacamr/dlaa113

Table 1.

Characteristics of cohort

Variable Frequency, n =301 %
Age, median (IQR), years 60 (45–68)
Female 118 39.2
PWID 21 7.0
Referring service
 orthopaedics 114 37.9
 medicine 46 15.3
 cellulitis clinic 30 10
 neurosurgery 21 0.7
 cardiovascular surgery 16 5.3
 gastroenterology 12 4
 cardiology 11 3.7
 infectious diseases 10 3.3
 otolaryngology 8 2.7
 general surgery 6 2
 plastic surgery 6 2
 thoracic surgery 5 1.7
 urology 5 1.7
 nephrology 3 1
 other 7 2.3
Indications for treatment
 infected joint (with or without hardware) 91 30.2
 skin and soft tissue infection 44 14.6
 osteomyelitis 40 13.3
 bacteraemia 34 11.3
 surgical site infection (non-joint related) 27 9
 endocarditis 22 7.3
 meningitis/epidural abscess 16 5.3
 intra-abdominal infection 13 4.3
 device-related infection (excluding bacteraemia) 8 2.7
 pneumonia with S. aureus 2 0.7
 other 4 1.3
Isolated microorganisms
 MRSA 102 33.9
coagulase-negative Staphylococcus 90 29.9
 Enterococcus spp. 20 6.6
 MSSA 6 2.0
 Cutibacterium acnes 5 1.7
 culture negative 68 22.6
other 10 3.3
Concurrent antimicrobial therapy
 none 152 50.5
 cephalosporin 54 17.9
 rifampicin 17 5.6
 piperacillin/tazobactam 34 11.3
 carbapenem 24 8.0
 fluoroquinolone 6 2.0
 trimethoprim/sulfamethoxazole 2 0.7
 aminoglycosides 2 0.7
 metronidazole 2 0.7
 tetracycline 1 0.3
 clindamycin 1 0.3
 antivirals 2 0.7
 oral vancomycin 1 0.3
 daptomycin 1 0.3
Source of culture specimen
 tissue 65 21.6
 blood 52 17.3
 fluid 22 7.3
 urine 1 0.3
 wound 67 22.3
 historic positive 20 6.6
 culture negative 73 24.3
 missing 1 0.3
Target level of vancomycin trough level
 10–15 mg/L 103 34.2
 15–20 mg/L 125 41.5
 10–20 mg/L 73 24.2